| Table of Contents |  |
|
Editorial
| ||||||
| Multikinase inhibitors in the setting of thyroid carcinoma | ||||||
| Maria João Bugalho1,2,3 | ||||||
|
1Serviço de Endocrinologia, Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E., Rua Professor Lima Basto, 1099-023 Lisboa, Portugal.
2Unidade de Investigação de Patobiologia Molecular, Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Rua Professor Lima Basto, 1099-023 Lisboa, Portugal. 3NOVA Medical School / Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Campo dos Mártires da Pátria, 130, 1169-056 Lisboa, Portugal. | ||||||
| ||||||
|
[HTML Full Text]
[PDF Full Text]
[Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar] |
| How to cite this article |
| Bugalho MJ. Multikinase inhibitors in the setting of thyroid carcinoma. Edorium J Endocrinol 2015;2:5–9. |
|
Abstract
|
|
No Abstract
|
|
[HTML Full Text]
[PDF Full Text]
|
|
Author Contributions:
Maria João Bugalho – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published |
|
Guarantor of submission
The corresponding author is the guarantor of submission. |
|
Source of support
None |
|
Conflict of interest
Authors declare no conflict of interest. |
|
Copyright
© 2015 Maria João Bugalho. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information. |
|
|